ASVRX
Price
$10.61
Change
+$0.09 (+0.86%)
Updated
Aug 21 closing price
Net Assets
2.96B
FRVLX
Price
$68.52
Change
+$0.18 (+0.26%)
Updated
Aug 21 closing price
Net Assets
4.29B
Interact to see
Advertisement

ASVRX vs FRVLX

ASVRX vs FRVLX Comparison Chart in %
View a ticker or compare two or three
VS
ASVRX vs. FRVLX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASVRX is a Hold and FRVLX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FRVLX has more cash in the bank: 4.29B vs. ASVRX (2.96B). FRVLX pays higher dividends than ASVRX: FRVLX (0.81) vs ASVRX (0.42). ASVRX was incepted earlier than FRVLX: ASVRX (16 years) vs FRVLX (30 years). ASVRX (1.58) is less costly to investors than FRVLX (0.98). FRVLX is a more actively managed with annual turnover of: 52.73 vs. ASVRX (42.00). FRVLX has a lower initial minimum investment than ASVRX: FRVLX (1000) vs ASVRX (2500). FRVLX annual gain was more profitable for investors over the last year : 21.29 vs. ASVRX (7.69). FRVLX return over 5 years is better than : 18.41 vs. ASVRX (1.09).
ASVRXFRVLXASVRX / FRVLX
Total Expense Ratio1.580.97163%
Annual Report Gross Expense Ratio1.580.98161%
Fund Existence16 years30 years-
Gain YTD23.66023.016103%
Front LoadN/A6%-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets2.96B4.29B69%
Annual Yield % from dividends0.420.8152%
Returns for 1 year7.6921.2936%
Returns for 3 years17.8336.7649%
Returns for 5 years1.0918.416%
Returns for 10 years31.4735.2489%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNR9.780.53
+5.73%
Burning Rock Biotech Limited
STLA5.410.15
+2.85%
Stellantis NV
TNET70.481.78
+2.59%
Trinet Group
MTR2.67N/A
-0.19%
Mesa Royalty Trust
AGMB13.25-0.18
-1.34%
Agomab Therapeutics NV